Latest period
$235.36M
YoY change
+105.2%
5Y CAGR
-4.5%
Peak year (2021)
$223.33M
Latest annual
$94.00M
Total Assets history chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: $94.00M
Total Assets growth chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: +105.2%
Total Assets history table for Relmada Therapeutics (RLMD) from 2012 to 2025
| 2025 | $94.00M | +105.2% | +$48.19M | ||
| 2024 | $45.82M | -53.0% | −$51.73M | ||
| 2023 | $97.55M | -36.2% | −$55.35M | ||
| 2022 | $152.91M | -31.5% | −$70.42M | ||
| 2021 | $223.33M | +89.0% | +$105.14M | ||
| 2020 | $118.19M | +0.9% | +$1.05M | ||
| 2019 | $117.14M | +1046.2% | +$106.92M | ||
| 2018 | $10.22M | +235.3% | +$7.17M | ||
| 2017 | $3.05M | +7.4% | +$211.16K | ||
| 2016 | $2.84M | -72.3% | −$7.41M | ||
| 2015 | $10.24M | -58.0% | −$14.15M | ||
| 2014 | $24.39M | -5.3% | −$1.37M | ||
| 2013 | $25.76M | +140275.1% | +$25.75M | ||
| 2012 | $18.35K | — | — |
- 2025$94.00M+105.2%
- 2024$45.82M-53.0%
- 2023$97.55M-36.2%
- 2022$152.91M-31.5%
- 2021$223.33M+89.0%
- 2020$118.19M+0.9%
- 2019$117.14M+1046.2%
- 2018$10.22M+235.3%
- 2017$3.05M+7.4%
- 2016$2.84M-72.3%
- 2015$10.24M-58.0%
- 2014$24.39M-5.3%
- 2013$25.76M+140275.1%
- 2012$18.35K—
Total Assets values are taken from Relmada Therapeutics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at Relmada Therapeutics (RLMD)
According to Relmada Therapeutics's latest reported financial statements, the company's latest reported total assets is $235.36M. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Relmada Therapeutics (RLMD) reported total assets of $94.00M – surged 105.2% year-over-year.
Relmada Therapeutics total assets has contracted on net over the period, with a -4.5% compound annual growth rate over 2020–2025 (5 years).
Relmada Therapeutics total assets plunged from $223.33M in 2021 to $94.00M in 2025, a 57.9% drawdown.
The record annual total assets stands at $223.33M, reached in 2021; the historical low of $18.35K was recorded in 2012.
Relmada Therapeutics Total Assets by Year
Relmada Therapeutics Total Assets 2025: $94.00M
Relmada Therapeutics total assets in 2025 was $94.00M, surged 105.2% from 2024.
Relmada Therapeutics Total Assets 2024: $45.82M
2024's total assets for Relmada Therapeutics came in at $45.82M, plunged 53.0% below 2023.
Relmada Therapeutics Total Assets 2023: $97.55M
Relmada Therapeutics posted total assets of $97.55M in 2023, plunged 36.2% below 2022.
Relmada Therapeutics Total Assets 2022: $152.91M
In 2022, Relmada Therapeutics reported total assets of $152.91M, plunged 31.5% below 2021.
Relmada Therapeutics Total Assets 2021: $223.33M
Relmada Therapeutics total assets in 2021 was $223.33M.
See more financial history for Relmada Therapeutics (RLMD).
Sector peers by Total Assets
Healthcare peers of Relmada Therapeutics (RLMD), ranked by their latest total assets
| $309.58B | |
| $199.21B | |
| $136.87B | |
| $133.96B | |
| $114.07B | |
| $112.48B | |
| $90.59B | |
| $85.37B |
- $309.58B
- $199.21B
- $136.87B
- $133.96B
- $114.07B
- $112.48B
- $90.59B
- $85.37B
Frequently asked questions
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation